Overview The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients Status: Completed Trial end date: 2017-12-19 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the effect of BMS-986165 in combination with an oral contraceptive in healthy female patients. Phase: Phase 1 Details Lead Sponsor: Bristol-Myers SquibbTreatments: BMS-986165Contraceptive AgentsContraceptives, OralEstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valerateEthinyl EstradiolMestranolNorethindroneNorethindrone AcetateNorethindrone acetate, ethinyl estradiol, ferrous fumarate drug combinationNorinylPolyestradiol phosphate